32846-64-3 Usage
Uses
Used in Chemical Synthesis:
4,7-dibromotricyclo[5.2.1.0~2,6~]deca-4,8-diene-3,10-dione is used as a building block for the synthesis of various complex organic compounds, particularly cubanes. Its unique structure and bromine atoms make it a valuable intermediate in the construction of these molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4,7-dibromotricyclo[5.2.1.0~2,6~]deca-4,8-diene-3,10-dione may be utilized as a starting material for the development of new drugs or drug candidates. Its structural properties could be exploited to design molecules with specific biological activities or to improve the properties of existing drugs.
Used in Material Science:
4,7-dibromotricyclo[5.2.1.0~2,6~]deca-4,8-diene-3,10-dione may also find applications in material science, where its unique structure and properties could be used to develop new materials with specific characteristics, such as improved stability, reactivity, or selectivity in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 32846-64-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,8,4 and 6 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 32846-64:
(7*3)+(6*2)+(5*8)+(4*4)+(3*6)+(2*6)+(1*4)=123
123 % 10 = 3
So 32846-64-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H6Br2O2/c11-6-3-5-7(8(6)13)4-1-2-10(5,12)9(4)14/h1-5,7H
32846-64-3Relevant academic research and scientific papers
Structure-activity relationships of N-substituted 4-(trifluoromethoxy) benzamidines with affinity for GluN2B-containing NMDA receptors
Beinat, Corinne,Banister, Samuel D.,Hoban, Jane,Tsanaktsidis, John,Metaxas, Athanasios,Windhorst, Albert D.,Kassiou, Michael
, p. 828 - 830 (2014/02/14)
GluN2B subtype-selective NMDA antagonists represent promising therapeutic targets for the symptomatic treatment of multiple CNS pathologies. A series of N-benzyl substituted benzamidines were synthesised and the benzyl ring was further replaced with various polycyclic moieties. Compounds were evaluated for activity at GluN2B containing NMDA receptors where analogues 9, 12, 16 and 18 were the most potent of the series, replacement of the benzyl ring with polycycles resulted in a complete loss of activity.
